blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0644900

EP0644900 - A MONOCLONAL ANTIBODY TO A HUMAN MDR1 MULTIDRUG RESISTANCE GENE PRODUCT, AND ITS USE [Right-click to bookmark this link]
Former [1995/13]A MONOCLONAL ANTIBODY TO A HUMAN MDR1 MULTIDRUG RESISTANCE GENE PRODUCT, AND USES
[2002/35]
StatusNo opposition filed within time limit
Status updated on  16.04.2004
Database last updated on 07.10.2024
Most recent event   Tooltip28.05.2004Lapse of the patent in a contracting state
New state(s): DK
published on 14.07.2004  [2004/29]
Applicant(s)For all designated states
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
352 Henry Administration Building
506 South Wright Street
Urbana-Champaign, IL 61801 / US
[N/P]
Former [2002/43]For all designated states
The Board of Trustees of the University of Illinois
352 Henry Administration Building 506 South Wright Street
Urbana-Champaign, IL 61801 / US
Former [1995/13]For all designated states
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
346 Henry Administration Building
Urbana-Champaign, IL 60611 / US
Inventor(s)01 / MECHETNER, Eugene
5325 South Hyde Park Blvd., Apt. 1B
Chicago, IL 60615 / US
02 / RONINSON, Igor, B.
2731 Lincoln Lane
Wilmette, IL 60091 / US
[1995/13]
Representative(s)Bizley, Richard Edward, et al
Avidity IP
Broers Building
Hauser Forum
21 J J Thomson Ave
Cambridge CB3 0FA / GB
[N/P]
Former [1995/13]Bizley, Richard Edward, et al
Hepworth, Lawrence, Bryer & Bizley Merlin House Falconry Court Bakers Lane
Epping Essex CM16 5DQ / GB
Application number, filing date93908345.717.03.1993
[1995/13]
WO1993US02347
Priority number, dateUS1992085488120.03.1992         Original published format: US 854881
US1993003205616.03.1993         Original published format: US 32056
[1995/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9319094
Date:30.09.1993
Language:EN
[1993/24]
Type: A1 Application with search report 
No.:EP0644900
Date:29.03.1995
Language:EN
The application published by WIPO in one of the EPO official languages on 30.09.1993 takes the place of the publication of the European patent application.
[1995/13]
Type: B1 Patent specification 
No.:EP0644900
Date:11.06.2003
Language:EN
[2003/24]
Search report(s)International search report - published on:US30.09.1993
(Supplementary) European search report - dispatched on:EP13.11.1995
ClassificationIPC:C12N15/13, C12N5/20, C12P21/08, C07K16/18, G01N33/53, A61K39/395
[2003/23]
CPC:
C07K16/28 (EP,US); C07K2/00 (KR); A61K39/395 (KR);
A61P35/00 (EP); C12N5/12 (KR); A61K38/00 (EP,US);
C07K2319/00 (EP,US) (-)
Former IPC [1995/51]C12N15/13, C12N5/20, C12P21/08, C07K15/06, G01N33/53, A61K39/395
Former IPC [1995/13]C07K15/28, C12N5/20, C12P21/08, C07K15/06, G01N33/53, A61K39/395
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1995/13]
TitleGerman:MONOKLONALER ANTIKÖRPER GEGEN EIN HUMANES MDR1-GEN PRODUKT, DAS EINE RESISTENZ GEGEN VERSCHIEDENE MEDIKAMENTE ERZEUGT UND SEINE VERWENDUNG[1995/13]
English:A MONOCLONAL ANTIBODY TO A HUMAN MDR1 MULTIDRUG RESISTANCE GENE PRODUCT, AND ITS USE[2002/35]
French:UN ANTICORPS MONOCLONAL DIRIGE CONTRE UN PRODUIT DU GENE MDR-1 HUMAIN QUI CONFERE UNE RESISTANCE A PLUSIEURS MEDICAMENTS ET SON UTILISATION[2002/35]
Former [1995/13]A MONOCLONAL ANTIBODY TO A HUMAN MDR1 MULTIDRUG RESISTANCE GENE PRODUCT, AND USES
Former [1995/13]ANTICORPS MONOCLONAL DIRIGE CONTRE UN PRODUIT GENIQUE MDR1 RESISTANT A L'EFFET DE PLUSIEURS MEDICAMENTS ET PROCEDES D'UTILISATION ASSOCIES
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase20.10.1994National basic fee paid 
20.10.1994Search fee paid 
20.10.1994Designation fee(s) paid 
20.10.1994Examination fee paid 
Examination procedure20.10.1993Request for preliminary examination filed
International Preliminary Examining Authority: US
20.10.1994Examination requested  [1995/13]
07.08.2000Despatch of a communication from the examining division (Time limit: M06)
19.02.2001Reply to a communication from the examining division
20.02.2002Despatch of a communication from the examining division (Time limit: M04)
19.06.2002Reply to a communication from the examining division
27.08.2002Communication of intention to grant the patent
03.01.2003Fee for grant paid
03.01.2003Fee for publishing/printing paid
Opposition(s)12.03.2004No opposition filed within time limit [2004/23]
Fees paidRenewal fee
13.03.1995Renewal fee patent year 03
07.03.1996Renewal fee patent year 04
24.01.1997Renewal fee patent year 05
17.04.1998Renewal fee patent year 06
08.02.1999Renewal fee patent year 07
06.03.2000Renewal fee patent year 08
05.03.2001Renewal fee patent year 09
22.03.2002Renewal fee patent year 10
24.03.2003Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
31.03.199806   M06   Fee paid on   17.04.1998
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT11.06.2003
DK11.09.2003
GR11.09.2003
PT11.09.2003
[2004/29]
Former [2004/03]AT11.06.2003
GR11.09.2003
PT11.09.2003
Former [2004/02]GR11.09.2003
PT11.09.2003
Documents cited:Search[A]EP0267781  (ONTARIO CANCER INST [CA]);
 [A]  - CHEVALLIER-MULTON ET AL, "IMPORTANCE OF THE FOURTH EXTERNAL LOOP IN IMMUNOGENICITY OF THE MULTIDRUG RESISTANCE RELATED P-GLYCOPROTEIN", JOURNAL OF CELLULAR PHARMACOLOGY, vol. 2, pages 165 - 170 [A] 1-25 * the whole document *
 [A]  - YANG ET AL, "THE FIRST EXTRACELLULAR DOMAIN OF P170 GLYCOPROTEIN: CHARACTERIZATION OF STRUCTURE AND FUNCTION WITH A MONOCLONAL ANTI-PEPTIDE ANTIBODY", PROCEEDINGS OF THE AMERICAN ASSOCATION FOR CANCER RESEARCH, vol. 31, page 376, XP000943327 [A] 1-25 * abstract 2232 *
 [PX]  - CHAUDHARY ET AL, "EXPRESSION AND ACTIVITY OF THE MULTIDRUG RESISTANCE P-GLYCOPROTEIN IN HUMAN PERIPHERAL BLOOD LYMPHOCYTES", BLOOD, vol. 80, no. 11, pages 2735 - 2739 [PX] 1-25 * the whole document *
 [PX]  - MECHETNER ET AL, "EFFICIENT INHIBITION OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE WITH A MONOCLONAL ANTIBODY", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 89, doi:doi:10.1073/pnas.89.13.5824, pages 5824 - 5828, XP002060367 [PX] 1-25 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.89.13.5824
 [OPX]  - NISHII ET AL, "P-GLYCOPROTEIN EXPRESSION IN HUMAN LYMPH NODE", THE MECHANISM AND NEW APPROACH ON DRUG RESISTANCE OF CANCER CELLS.PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON THE MECHANISM AND NEW APPROACH ON DRUG RESISTANCE OF CANCER CELLS.1993 EXCERPTA MEDICA, SAPPORO, pages 37 - 43 [OPX] 1-25 * the whole document *
International search[Y]US4925787  (TANIHARA MASAO [JP], et al);
 [Y]US5091513  (HUSTON JAMES S [US], et al)
 [Y]  - Nature, Volume 348, issued 06 December 1990, JOHN McCAFFERTY et al., "Phage Antibodies: Filamentous Phage Displaying Antibody Variable Domains", pages 552-554, see entire document.
 [Y]  - Proceedings of the National Academy of Sciences, Volume 83, issued October 1986, HIROFUMI HAMADA et al., "Functional Role for the 170-to 180-kDa Glycoprotein Specific to Drug-Resistant Tumor Cells as Revealed by Monoclonal Antibodies", pages 7785-7789, see entire document.
 [Y]  - Cancer Research, Volume 49, No. 12, issued 15 June 1989, MARIAN MEYERS et al., "Characterization of Monoclonal Antibodies Recognizing M 180,000 P-Glycoprotein: Differential Expression of the Mr 180,000 and Mr 170,000 P-Glycoproteins in Multidrug-Resistant Human Tumor Cells", pages 3209-3214, see entire document.
 [Y]  - Cancer, Volume 66, No. 5, issued 01 September 1990, YASUO KAWAZURU et al., "Expression of the Multidrug Transporter, P-Glycoprotein, in Acute Leukemia Cells and Correlation to Clinical Drug Resistance", pages 868-873, see entire document.
 [Y]  - Molecular and Cellular Biology, Volume 6, No. 10, issued November 1986, D.W. SHEN et al., "Multidrug Resistance of DNA-Mediated Transformants is Linked to Transfer of the Human mdr1 Gene", pages 4039-4045, see entire document.
 [Y]  - Monoclonal Antibodies '84: Biological and Clinical Applications, published 1985, P.E. THORPE, "Antibody Carriers of Cytotoxic Agents in Cancer Therapy: A Review", pages 475-506, see entire document.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.